Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Katleen Vereecken"'
Autor:
Elvis Achondou Akomoneh, Zina Gestels, Saïd Abdellati, Katleen Vereecken, Koen Bartholomeeusen, Dorien Van den Bossche, Chris Kenyon, Sheeba Santhini Manoharan-Basil
Publikováno v:
Antibiotics, Vol 12, Iss 11, p 1592 (2023)
The growing global threat of antimicrobial resistance is reaching a crisis point as common bacterial infections, including those caused by pathogenic Neisseria species, are becoming increasingly untreatable. This is compelling the scientific communit
Externí odkaz:
https://doaj.org/article/e608955a6e25461b8c07f47b1b8ad0fc
Autor:
Kevin K. Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken, Kurt Van Lent, Sandra Coppens, Betty Willems, Pieter Pannus, Geert A. Martens, Marjan Van Esbroeck, Maria E. Goossens, Arnaud Marchant, Koen Bartholomeeusen, Isabelle Desombere
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-3 (2022)
Abstract We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations sup
Externí odkaz:
https://doaj.org/article/9bc238c2683c4e7b91172cdf90ae834f
Autor:
Lien De Caluwé, Sandra Coppens, Katleen Vereecken, Simon Daled, Maarten Dhaenens, Xaveer Van Ostade, Dieter Deforce, Kevin K. Ariën, Koen Bartholomeeusen
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Chikungunya virus (CHIKV) is an arbovirus with a global spread and significant public health impact. It is a positive stranded RNA alphavirus belonging to the Togaviridae family. However, many questions about the replication cycle of CHIKV remain una
Externí odkaz:
https://doaj.org/article/5b6e64bea875423797e4623ca4886725
Autor:
Lien De Caluwé, Leo Heyndrickx, Sandra Coppens, Katleen Vereecken, Miguel E. Quiñones-Mateu, Andres Merits, Kevin K. Ariën, Koen Bartholomeeusen
Publikováno v:
Viruses, Vol 14, Iss 2, p 282 (2022)
Chikungunya virus (CHIKV) is an emerging arthropod-borne virus that has spread globally during the last two decades. The virus is mainly transmitted by Aedes aegypti and Aedes albopictus mosquitos and is thus capable of replicating in both human and
Externí odkaz:
https://doaj.org/article/0a2d08d009694d7dbbf89538fc56a9f9
Autor:
Sunita S Balla-Jhagjhoorsingh, Davide Corti, Leo Heyndrickx, Elisabeth Willems, Katleen Vereecken, David Davis, Guido Vanham
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68863 (2013)
Immunogen design for HIV-1 vaccines could be based on epitope identification of naturally occurring neutralizing antibodies in infected patients. A tier 2 neutralizing monoclonal antibody (mAb), HJ16 recognizes a new epitope in the CD4 binding site (
Externí odkaz:
https://doaj.org/article/7f92aeb3878d4fa3843e47aaabbfeeb0
Autor:
Leo Heyndrickx, Guillaume Stewart-Jones, Marianne Jansson, Hanneke Schuitemaker, Emma Bowles, Luigi Buonaguro, Berit Grevstad, Lasse Vinner, Katleen Vereecken, Joe Parker, Meghna Ramaswamy, Priscilla Biswas, Guido Vanham, Gabriella Scarlatti, Anders Fomsgaard, NGIN Consortium
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74552 (2013)
BACKGROUND: Ten to 30% of HIV-1 infected subjects develop broadly neutralizing antibodies (bNAbs) during chronic infection. We hypothesized that immunizing rabbits with viral envelope glycoproteins (Envs) from these patients may induce bNAbs, when fo
Externí odkaz:
https://doaj.org/article/37edf8c11d924b2381a98fc5660b5381
Autor:
Ellen Van Gulck, Nathalie Cools, Derek Atkinson, Lotte Bracke, Katleen Vereecken, Marc Vekemans, Viggo F. I. Van Tendeloo, Zwi N. Berneman, Guido Vanham
Publikováno v:
Clinical and Developmental Immunology, Vol 2012 (2012)
A variety of immune-based therapies has been developed in order to boost or induce protective CD8+ T cell responses in order to control HIV replication. Since dendritic cells (DCs) are professional antigen-presenting cells (APCs) with the unique capa
Externí odkaz:
https://doaj.org/article/4f4ef63f4f194d7eb9a4193900256c44
Autor:
Sunita S Balla-Jhagjhoorsingh, Betty Willems, Liesbeth Heyndrickx, Leo Heyndrickx, Katleen Vereecken, Wouter Janssens, Michael S Seaman, Davide Corti, Antonio Lanzavecchia, David Davis, Guido Vanham
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e25488 (2011)
Several new human monoclonal antibodies (mAbs) with a neutralizing potential across different subtypes have recently been described. Three mAbs, HJ16, HGN194 and HK20, were obtained from patients within the HIV-1 cohort of the Institute of Tropical M
Externí odkaz:
https://doaj.org/article/9d87a2f7f0fe4fb2a7565cbd57cd24fa
Autor:
Kevin K. Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken, Kurt Van Lent, Sandra Coppens, Betty Willems, Pieter Pannus, Geert A. Martens, Marjan Van Esbroeck, Maria E. Goossens, Arnaud Marchant, Koen Bartholomeeusen, Isabelle Desombere
Publikováno v:
npj Vaccines
We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f6c0a3f23de673baca77069891b2bd
https://pubmed.ncbi.nlm.nih.gov/35260578
https://pubmed.ncbi.nlm.nih.gov/35260578
Autor:
Kevin K. Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken, Kurt Van Lent, Sandra Coppens, Pieter Pannus, Geert A. Martens, Marjan Van Esbroeck, Maria E. Goossens, Arnaud Marchant, Koen Bartholomeeusen, Isabelle Desombere
We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in healthy individuals pre-infected or not with SARS-CoV-2 and immunized with three doses of the BNT162b2 vaccine. Our observations support the rapid administra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65652bf07fbe347c6182b5afb5431871
https://doi.org/10.1101/2021.12.23.21268316
https://doi.org/10.1101/2021.12.23.21268316
